Achilles Therapeutics Statistics
Total Valuation
ACHL has a market cap or net worth of $42.94 million. The enterprise value is -$47.71 million.
Important Dates
The next estimated earnings date is Friday, November 15, 2024, after market close.
| Earnings Date | Nov 15, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
ACHL has 41.09 million shares outstanding. The number of shares has increased by 1.71% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 41.09M |
| Shares Change (YoY) | +1.71% |
| Shares Change (QoQ) | +0.19% |
| Owned by Insiders (%) | 6.51% |
| Owned by Institutions (%) | 19.73% |
| Float | 20.83M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.37 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.24, with a Debt / Equity ratio of 0.04.
| Current Ratio | 8.24 |
| Quick Ratio | 7.94 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -44.22% and return on invested capital (ROIC) is -29.19%.
| Return on Equity (ROE) | -44.22% |
| Return on Assets (ROA) | -26.82% |
| Return on Capital (ROIC) | -29.19% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$297,521 |
| Employee Count | 215 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ACHL has paid $466,000 in taxes.
| Income Tax | 466,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +16.37% in the last 52 weeks. The beta is 1.34, so ACHL's price volatility has been higher than the market average.
| Beta (5Y) | 1.34 |
| 52-Week Price Change | +16.37% |
| 50-Day Moving Average | 0.92 |
| 200-Day Moving Average | 0.93 |
| Relative Strength Index (RSI) | 67.13 |
| Average Volume (20 Days) | 90,478 |
Short Selling Information
| Short Interest | 212,546 |
| Short Previous Month | 358,114 |
| Short % of Shares Out | 0.84% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 0.12 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -70.61M |
| Pretax Income | -64.01M |
| Net Income | -63.97M |
| EBITDA | -65.90M |
| EBIT | -70.61M |
| Earnings Per Share (EPS) | -$1.59 |
Full Income StatementBalance Sheet
The company has $95.11 million in cash and $4.46 million in debt, giving a net cash position of $90.65 million or $2.21 per share.
| Cash & Cash Equivalents | 95.11M |
| Total Debt | 4.46M |
| Net Cash | 90.65M |
| Net Cash Per Share | $2.21 |
| Equity (Book Value) | 115.48M |
| Book Value Per Share | 2.81 |
| Working Capital | 103.52M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$48.00 million and capital expenditures -$840,000, giving a free cash flow of -$48.84 million.
| Operating Cash Flow | -48.00M |
| Capital Expenditures | -840,000 |
| Free Cash Flow | -48.84M |
| FCF Per Share | -$1.19 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |